Alifiya H. Ghadiali

FDA investigator

Appears on 2 documents from 2024 to 2025, mostly at sites in Maryland. Most often cites responsibilities of quality control unit (21 CFR 211.22).

2
Documents on file
4.0
Observations per 483
2024
First seen
2025
Most recent

What they cite most

From 11 observations

Activity by year

2024: 1, 2025: 1

Where

Maryland 1 · North Carolina 1

Often inspects with

Jin Sung Hong· Laura Ricles· Ou Olivia Ma

Is Alifiya H. Ghadiali coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 FDA Form 483 Catalent Harmans April 2025Apr 28, 2025 · Harmans, Maryland
483 Humacyte Global, IncApr 5, 2024 · Durham, North Carolina

About this profile

What does Alifiya H. Ghadiali inspect?

Alifiya H. Ghadiali appears on 2 documents on file covering 2 sites, mostly in Maryland.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.25 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Alifiya H. Ghadiali is dated Apr 28, 2025.